Sosei Group Revenue and Competitors

Tokyo,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Sosei Group's estimated annual revenue is currently $35.3M per year.(i)
  • Sosei Group's estimated revenue per employee is $155,000

Employee Data

  • Sosei Group has 228 Employees.(i)
  • Sosei Group grew their employee count by 9% last year.

Sosei Group's People

NameTitleEmail/Phone
1
Head Human ResourcesReveal Email/Phone
2
Head IPReveal Email/Phone
3
Head FinanceReveal Email/Phone
4
SVP Corporate StrategyReveal Email/Phone
5
General CounselReveal Email/Phone
6
Head Clinical OperationsReveal Email/Phone
7
Associate Director ‑ Translational SciencesReveal Email/Phone
8
Senior DirectorReveal Email/Phone
9
Senior Director Translational SciencesReveal Email/Phone
10
Director and Head BiochemistryReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Sosei Group?

We are an international biopharmaceutical group focused on the discovery and early development of new medicines originating from our proprietary GPCR-targeted StaR® technology and structure-based drug design platform capabilities. We are advancing a broad and deep pipeline of novel medicines across multiple therapeutic areas, including neurology, immunology, gastroenterology and inflammatory diseases. We have established partnerships with some of the world's leading pharmaceutical companies, including AbbVie, AstraZeneca, Genentech (Roche), Novartis, Pfizer and Takeda and additionally with multiple emerging technology companies. Sosei Heptares is headquartered in Tokyo, Japan with corporate and R&D facilities in Cambridge, UK. Sosei Heptares is the corporate brand of Sosei Group Corpoation, which is listed on the Tokyo Stock Exchange (ticker: 4565). For more information, please visit www.soseiheptares.com

keywords:N/A

N/A

Total Funding

228

Number of Employees

$35.3M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Sosei Group News

2022-04-20 - Sosei Heptares to Embed Agile Operating Model and Enhance its ...

TOKYO and CAMBRIDGE, United Kingdom, April 26, 2022 (GLOBE NEWSWIRE) -- Sosei Group Corporation (“the Company”; TSE: 4565) today announces a...

2022-04-20 - Sosei Heptares to Embed Agile Operating Model and Enhance its ...

Tokyo, Japan and Cambridge, UK, 26 April 2022 – Sosei Group Corporation (“the Company”; TSE: 4565) today announces a strategic collaboration...

2022-03-22 - Sosei Heptares confirms new leadership focused on driving growth from its Granta Park R&D centre

Hironoshin Nomura becomes CFO and Kieran Johnson becomes chief accounting officer in other changes at the company, which said the new team would...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35.3M2289%N/A
#2
$88.2M24311%N/A
#3
$40.5M2549%N/A
#4
$37.3M261110%$260.4M
#5
$39.2M27440%N/A